No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BTIG Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $40
Avalo Therapeutics Initiated With a Buy at BTIG
Express News | Avalo Therapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $40
Avalo Therapeutics Analyst Ratings
Lucid Capital Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $24
Avalo Therapeutics (AVTX) Is a Potential Hidden Gem With Significant Risk